Obiettivo "Our ITN has both scientific and therapeutic targets. Research in Work Package 1 (WP1) aims to advance understanding of normal blood cell development and why primitive cells fail to differentiate in acute myeloid leukaemia (AML). Research in WP2 will use the information gained from WP1 to develop ways of alleviating the differentiation block in AML and so deliver new agents for use in differentiation therapy. This type of therapy aims, using only mildly toxic treatments, to induce terminal maturation of leukaemia cells and accelerate their death. WP2 responds to the urgent need to devise milder treatments, especially for older and frailer AML patients. Participants have already identified a number of promising new therapeutic agents. Working across these two complementary areas will train our Early Stage Researchers (ESR) to understand the translation of new fundamental science into the development of new therapies. The ITN brings together scientists who have made important advances in the fields of haematopoiesis and differentiation therapy, so will provide an excellent scientific training in these areas. Secondments/visits by ESRs to participants who run centres of expertise in leading edge technologies will provide training in these; and the time spent with private sector participants, and the courses they provide, will ensure that ESRs acquire the transferable skills they will need if they are to work well in, and build bridges between, commercial and publicly funded research organisations. ESRs will also receive management training. This research and training, which will develop our ESRs as versatile scientists, will involve the combined efforts of prestigious research institutes and universities, Poland’s leading governmental pharmaceutical R & D institute, two successful biopharmaceutical companies and a leading management consultancy." Campo scientifico medical and health sciencesclinical medicineoncologyleukemia Programma(i) FP7-PEOPLE - Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) Argomento(i) FP7-PEOPLE-2012-ITN - Marie-Curie Action: "Initial Training Networks" Invito a presentare proposte FP7-PEOPLE-2012-ITN Vedi altri progetti per questo bando Meccanismo di finanziamento MC-ITN - Networks for Initial Training (ITN) Coordinatore THE UNIVERSITY OF BIRMINGHAM Contributo UE € 753 274,50 Indirizzo Edgbaston B15 2TT Birmingham Regno Unito Mostra sulla mappa Regione West Midlands (England) West Midlands Birmingham Tipo di attività Higher or Secondary Education Establishments Contatto amministrativo May Chung (Ms.) Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Costo totale Nessun dato Partecipanti (7) Classifica in ordine alfabetico Classifica per Contributo UE Espandi tutto Riduci tutto UNIVERSITY OF GALWAY Irlanda Contributo UE € 550 419,30 Indirizzo UNIVERSITY ROAD H91 Galway Mostra sulla mappa Regione Ireland Northern and Western West Tipo di attività Higher or Secondary Education Establishments Contatto amministrativo Mari Vahey (Ms.) Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Costo totale Nessun dato UNIVERSITAT BASEL Svizzera Contributo UE € 496 573,88 Indirizzo PETERSPLATZ 1 4051 Basel Mostra sulla mappa Regione Schweiz/Suisse/Svizzera Nordwestschweiz Basel-Stadt Tipo di attività Higher or Secondary Education Establishments Contatto amministrativo Antonius Rolink (Prof.) Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Costo totale Nessun dato UNIWERSYTET WROCLAWSKI Polonia Contributo UE € 249 205,66 Indirizzo PL UNIWERSYTECKI 1 50137 Wroclaw Mostra sulla mappa Regione Makroregion południowo-zachodni Dolnośląskie Miasto Wrocław Tipo di attività Higher or Secondary Education Establishments Contatto amministrativo Ewa Marcinkowska (Dr.) Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Costo totale Nessun dato ORBSEN THERAPEUTICS LIMITED Irlanda Contributo UE € 244 814,45 Indirizzo UNIT 1 GALWAY BUSINESS PARK H91 Galway Mostra sulla mappa Regione Ireland Eastern and Midland Dublin Tipo di attività Private for-profit entities (excluding Higher or Secondary Education Establishments) Contatto amministrativo Stephen Elliman (Dr.) Collegamenti Contatta l’organizzazione Opens in new window Costo totale Nessun dato INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG Regno Unito Contributo UE € 285 056,62 Indirizzo OLD BROMPTON ROAD 123 SW7 3RP London Mostra sulla mappa Regione London Inner London — West Kensington & Chelsea and Hammersmith & Fulham Tipo di attività Higher or Secondary Education Establishments Contatto amministrativo Yodry Vasquez (Mr.) Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Costo totale Nessun dato SIEC BADAWCZA LUKASIEWICZ - INSTYTUT FARMACEUTYCZNY Polonia Contributo UE € 448 620,90 Indirizzo UL. RYDYGIERA 8 01 793 Warszawa Mostra sulla mappa Regione Makroregion województwo mazowieckie Warszawski stołeczny Miasto Warszawa Tipo di attività Other Contatto amministrativo Andrzej Kutner (Dr.) Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Costo totale Nessun dato CELENTYX LIMITED Regno Unito Contributo UE € 285 056,62 Indirizzo VINCENT DRIVE 97 B15 2SQ BIRMINGHAM Mostra sulla mappa Tipo di attività Private for-profit entities (excluding Higher or Secondary Education Establishments) Contatto amministrativo Catherine Brady (Dr.) Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Costo totale Nessun dato
